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CORRESPONDENCE
Severe Measles Pneumonitis in Adults
SIR- We read with interest the report by Fomi et al. [1] describing
six cases of severe measles pneumonitis in adults. They describe
myositis as an uncommon clinical feature of the disease and pro-
vide circumstantial evidence for the efficacy of intravenous riba-
varin therapy in this clinical setting. We recently cared for two
adult patients with severe measles; one of these patients evidenced
marked elevation of creatine phosphokinase (CPK) activity, and
the second, whose infection was acquired nosocomially, developed
pneumonitis requiring mechanical ventilation. A third case, which
was also nosocomial, was mild.
Patient 1. A 24-year-old Swiss male presented with fever,
diarrhea, dyspnea, and a cough upon return from a vacation in the
Philippines. On physical examination his temperature was 39.2°C
and his respirations were 24/min; a macular, disseminated rash
and conjunctival injection were noted. There were no muscular
signs or symptoms. Laboratory values are shown in table 1. Find-
ings on chest roentgenogram were normal. After some delay, a
diagnosis of measles was made. The patient's respiratory symp-
toms promptly resolved with administration of oxygen by nasal
cannula for 24 hours, and he became afebrile within 48 hours. He
was discharged on day 5. A serological test was strongly positive
for IgM antibodies to measles virus.
Patient 2. A 34-year-old nurse who cared briefly for patient
1 in the emergency department developed a fever (temperature
>39°C) 9 days later; the next day she noted a rash on her face.
Twelve days after exposure she presented with a temperature of
38.3°C, a dry cough, conjunctival and pharyngeal injection, and a
generalized macular rash. Two days later (5 days after her symp-
toms first appeared) she was hospitalized because of persistent
fever (temperature to 40°C) and dyspnea. Chest roentgenography
showed generalized bilateral alveolar infiltrates. On day 10 of the
illness, the patient was intubated because of severe respiratory
insufficiency. Amoxicillinlclavulanic acid was administered for
presumed bacterial superinfection. Mechanical ventilation was
continued for 3 days; the patient recovered uneventfully and was
discharged home after a hospital stay of 16 days. Seroconversion
for measles virus-specific antibodies occurred.
Patient 3. The radiology technician who performed chest
roentgenography for patient 1 developed mild clinical measles 10
days later. None of the three patients had a history of measles or
measles vaccination.
We could not explain the eightfold increase in the CPK level
in patient 1 until we read the article by Forni et al. [1], in which
the possible explanation of measles-induced myositis was pro-
vided. The possibility of an exercise-induced elevation of the CPK
level that could have been triggered by the patient's respiratory
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Table 1. Laboratory data for two patients with measles pneumonitis.
Parameter Patient 1 Patient 2
P02 (normal, >9.0 kPa)* 5.1 kPa 4.8 kPa
PC02 (normal, 5.0-6.0 kPa) 4.6 kPa 5.8 kPa
Hemoglobin level 15.2 g/dL 14.0 g/dL
Leukocyte count 7,100/mm3 4,400/mm3
Thrombocyte count 141,000/mm3 96,000/mm 3
Aspartate aminotransferase level
(normal, <40 UlL) 124 UlL 50 U/L
Alanine aminotransferase level
(normal, <40 U/L) 19 U/L 26 U/L
Lactate dehydrogenase level
(normal, <450 U/L) 1,863 U/L 1,563 U/L
Creatinine phosphokinase level
(normal, 10-190 U/L) 2,082 U/L 142 U/L
* While breathing room air.
effort in response to hypoxemia must be excluded since elevation
of the CPK levels persisted longer than did his respiratory distress.
This patient's hypoxemia can best be explained by the presence
of alveolitis that resolved spontaneously; findings on a chest roent-
genogram were unremarkable, and results of blood gas analysis
became normal within 36 hours. It is conceivable that myositis
has been unnoticed in previous cases because CPK studies were
not done routinely or because elevations in levels of aspartate
aminotransferase and lactate dehydrogenase were interpreted as
representing hepatitis when they in fact reflected myositis [2].
The case of patient 2 demonstrates that severe measles pneumo-
nitis in immunocompetent adults, even when intubation and me-
chanical ventilation are required, can have a favorable course in
the absence of specific therapeutic measures. Despite some evi-
dence for an effect ofribavarin in patients with measles [3,4], the
drug's value in adults has yet to be convincingly demonstrated.
Finally, this case, in which severe measles was acquired in the
hospital setting, reminds us of the potential hazard of nosocomial
measles and the need for strict adherence to recommendations for
immunization of hospital employees [5, 6].
Jacques Gubler, Regina Liithy, and Oswald Oelz
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Bronchoesophageal Fistula Due to Multidrug-Resistant
Tuberculosis in a Patient Infected with Human
Immunodeficiency Virus
SIR - Bronchoesophageal fistulas are classified as congenital or
acquired; the majority of those seen in adults are acquired. The
causes include malignancy, trauma, and infection. The infectious
agents that are responsible for these fistulas include Mycobacte-
rium tuberculosis, Histoplasma capsulatum, Actinomyces species,
and Treponema pallidum. Tuberculosis is the most cornmon cause
of inflammatory fistulas [I].
Porter et al. noted that <30 cases of tuberculous bronchoesopha-
geal fistulae (BEF) have been reported in the literature, and they
described three additional patients who were infected with HIV
[2]. All three of their patients were from areas where tuberculosis
is endemic and had CD4 lymphocyte counts of 20/rnm3, and all
three were infected with organisms that were susceptible to all
antituberculous drugs; two of the three patients had documented
medical response with closure of the fistula (one was lost to follow-
up). We also treated an HIV-infected patient who had a BEF due
to M. tuberculosis; however, this case had unique features.
A 48-year-old homosexual man from Argentina who was in-
fected with HIV presented to the hospital with a I-week history
of cough, dyspnea, and fever (temperature, 38.4°C). Physical ex-
amination revealed clear lungs and a nontender supraclavicular
lymph node. Chest radiographs demonstrated bilateral interstitial
and alveolar infiltrates. The patient received pentamidine for pre-
sumed Pneumocystis carinii pneumonia. His condition initially
improved, but then the infiltrates became more extensive and he
developed dysphagia.
Bronchoscopy, which was performed on hospital day 20, re-
vealed a 7-mm opening in the right main-stern bronchus below
the main carina, and polypoid white and black tissue was visible.
Histopathologic examination revealed squamous epithelium-lined
mucosa that was acutely and chronically inflamed; there were no
granulomas, but numerous acid-fast bacilli (AFB) were observed.
Transbronchial biopsy showed mild interstitial fibrosis, and Gro-
cott-Gomori methenamine-silver nitrate stains were negative for
P. carinii but positive for AFB. A barium swallow showed a BEF
below the level of the carina, with extravasation of barium into
the right bronchial tree. A CT scan of the chest revealed bilateral
infiltrates, mediastinal lymphadenopathy, and an air pocket corre-
sponding to the level of the fistula. A biopsy of the supraclavicular
lymph node was also performed, and a stain for AFB was positive.
The attending physician was then notified that the patient had
had multidrug-resistant tuberculosis (MDRTB) and that the M.
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tuberculosis isolate had been resistant to isoniazid, rifampin, eth-
ambutol, and pyrazinamide); he was treated with intravenous isoni-
azid (300 mg once a day), oral ethionamide (250 mg every 8
hours), intravenous amikacin (350 mg every 12 hours), oral rifa-
butin (300 mg every day), and oral cycloserine (250 mg every 8
hours). He received total parenteral nutrition and was permitted to
take only medications orally. Multidrug-resistant M. tuberculosis
was cultured from sputum, bronchoscopic washings, the supracla-
vicular lymph node, and gastric washings. The patient continued
to receive rifabutin, ethionamide, cycloserine, and amikacin, but
therapy with isoniazid was stopped. After 4 weeks, a repeated
barium swallow showed complete closure of the fistula, and the
patient resumed oral feedings without any intolerance. He was
discharged from the hospital 4 months after admission.
In the past few years, there have been numerous outbreaks of
MDRTB. Most cases of MDRTB have been in patients infected
with HIV [3]. MDRTB can occur as a result of infection by organ-
isms that are already resistant to antituberculous drugs or as a
result of the development, during treatment, of drug resistance in
a strain that was not present initially. It was previously believed
that infection with M. tuberculosis would protect against reinfec-
tion with the same organism because of acquired immunity. One
study [4] described five HIV-infected patients who were docu-
mented by restriction fragment length polymorphism to be infected
with initially susceptible isolates but who developed MDRTB dur-
ing treatment. It was concluded that they must have been exoge-
nously reinfected with a new strain of M. tuberculosis [4].
The mortality among patients with MDRTB has ranged from
72% to 89%, and the median interval between the diagnosis of
MDRTB and death has been short, ranging from 4 to 6 weeks [3].
The median hospital stay for patients with MDRTB is >7 months
[5]. Not only did our patient's condition improve, but he survived
after developing a devastating complication due to MDRTB and
his fistula closed as well. Follow-up cultures for M. tuberculosis
were negative. He died of progressive Kaposi's sarcoma and de-
mentia 2 months after discharge. Porter et al. stress that a diagnosis
of tuberculosis should be considered for HIV-infected individuals
with associated intrathoracic lymphadenopathy, fever, and dyspha-
gia and that antituberculous chemotherapy should be administered
pending culture results [2]. The possibility of MDRTB-induced
BEF should be kept in mind in areas where M. tuberculosis is
endemic. With appropriate antituberculous therapy and nutritional
support, a patient with an MDRTB-induced BEF should respond,
resulting in clearance of the infection as well as healing of the
fistula.
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